Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
CDCodexis, Inc. logo

Codexis, Inc. (CDXS)

NASDAQ Global Select · Currency in USD
$1.30 ▲ +0.02 (+1.56%)
At close: Oct 26, 4:00 PM ET. Market closed.
$1.31 ▲ +0.01 (+0.77%)
After hours: Oct 26, 4:31 PM ET

Summary

Previous Close
$1.28
Open
$1.29
Day's Range
$1.28 – $1.30
52 Week Range
$0.96 – $2.98
Volume
392,376
Avg. Volume
1,073,379
Market Cap
$142.36M
Beta (5Y Monthly)
2.55
PE Ratio (TTM)
--
EPS (TTM)
-$0.34
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$8.00

Profile: Codexis, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
146
CEO
Alison Moore

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.09 · Revenue est. $18.72M
DateEst.Actual
Aug 11, 2026-$0.14-$0.13Beat
May 7, 2026-$0.11-$0.10Beat
Mar 11, 2026$0.01$0.11Beat
Nov 6, 2025-$0.15-$0.22Miss
Aug 13, 2025-$0.17-$0.16Beat
May 14, 2025-$0.20-$0.25Miss

Analyst view

Consensus price target
$8.00 ▲ +515.4%
Range $5.00 – $11.00
Rating: Buy
Buy 64% · Hold 36% · Sell -0%

Get free alerts on CDXS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.